Found 201 articles for: "chemotherapy"
Eyebrow and Eyelash Loss in Patients With Cancer
May 2024 | Volume 23 | Issue 5 | Original Article | 8003 | Copyright © May 2024
Though it is widely acknowledged that cancer treatments cause hair loss on the scalp, there are limited data on how they affect eyebrow and eyelash hairs. Patients with eyebrow and eyelash loss, ...
Read MoreThe Use of Natural Therapies in Patients With Skin Cancer: A Scoping Review
May 2024 | Volume 23 | Issue 5 | Original Article | 8077 | Copyright © May 2024
Complementary and alternative medicine (CAM) use has become a field of growing interest in dermatology. However, the prevalence of CAM use is difficult to quantify as it varies based on many fact...
Read MoreMetastatic Merkel Cell Carcinoma After Simultaneous Pancreas-Kidney Transplantation: Fatal Outcomes
May 2024 | Volume 23 | Issue 5 | Case Reports | 8234 | Copyright © May 2024
Merkel cell carcinoma (MCC) is a rare, highly aggressive cutaneous malignancy. Immunosuppression increases the risk of MCC and is associated with poor prognosis. Organ transplant recipients (OTR)...
Read MoreHuman Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review
April 2024 | Volume 23 | Issue 4 | Original Article | 239 | Copyright © April 2024
Background: Bakuchiol is a topical cosmeceutical marketed as a retinoid alternative. Human clinical trial data on bakuchiol's efficacy for the treatment of dermatologic condition...
Read MoreTreatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis
April 2024 | Volume 23 | Issue 4 | Original Article | 216 | Copyright © April 2024
Background: Multiple treatment options exist for the management of moderate-to-severe acne. However, the comparative effectiveness (efficacy/safety) of moderate-to-severe acne tr...
Read MoreEffectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin Retrusion
April 2024 | Volume 23 | Issue 4 | Original Article | 255 | Copyright © April 2024
Background: A hyaluronic acid (HA) filler intended for non-surgical improvement of chin appearance should ideally be of high strength/firmness (high G') to allow for deep injecti...
Read MoreCutaneous Squamous Cell Carcinoma In Situ on a Fingernail Treated With HPV Vaccine
April 2024 | Volume 23 | Issue 4 | Case Reports | 275 | Copyright © April 2024
Atypical Dyschromia in Skin of Color
February 2024 | Volume 23 | Issue 2 | Case Reports | 100 | Copyright © February 2024
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with ...
Read MoreNeoadjuvant PD-1 Inhibitors: A Tale of Two Cases
February 2024 | Volume 23 | Issue 2 | Case Reports | e57 | Copyright © February 2024
Treatment responses for locally advanced cutaneous squamous cell carcinoma (cSCC) and Merkel cell carcinoma (MCC) are often short lived and are marred with recurrences. The introduction of adjuva...
Read MoreIncorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreA Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma
December 2023 | Volume 22 | Issue 12 | Case Reports | 1223 | Copyright © December 2023
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and extranodal involvement is seen in approximately 40% of cases. However, cases involving the skin and musc...
Read MoreINDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF389716s4 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MoreINDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF400354s3 | Copyright © November 2023
Background: In the Nordic European countries in 2020, cancer diagnoses accounted for 175,925 patients. About 50% of cancer patients receive radiation therapy (RT), which may lead...
Read MoreOff-Label Use of Baricitinib in Dermatology
August 2023 | Volume 22 | Issue 8 | Original Article | 795 | Copyright © August 2023
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib ...
Read MoreDiagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians
August 2023 | Volume 22 | Issue 8 | Original Article | 742 | Copyright © August 2023
Pediatric psoriasis (PsO) and its associated comorbidities carry physical and psychosocial burdens in children and adolescents, which can negatively impact quality of life. However, features dist...
Read MoreAntimalarials are not Effective as Pre-Exposure Prophylaxis for COVID-19: A Retrospective Matched Control Study
August 2023 | Volume 22 | Issue 8 | Editorials | 840 | Copyright © August 2023
The early phase of the COVID-19 pandemic prompted a repurposing of antiviral and immunomodulatory drugs as investigational therapeutics, including hydroxychloroquine and chloroquine. While antima...
Read MoreLeukemia Cutis in Skin of Color
July 2023 | Volume 22 | Issue 7 | Case Reports | 687 | Copyright © July 2023
The various presentations of many dermatologic conditions among various skin types are slowly being elucidated throughout the recent years. These differences present as an issue as it leads to de...
Read MoreModified Fitzpatrick Scale-Skin Color and Reactivity
July 2023 | Volume 22 | Issue 7 | Original Article | 641 | Copyright © July 2023
Background: There is growing interest in the development of a skin classification system that captures the world's diverse population. The Fitzpatrick skin classification scale i...
Read MoreEruptive Squamous Cell Carcinomas Following Treatment With Fludarabine and Discussion of Treatment
May 2023 | Volume 22 | Issue 5 | Case Reports | 509 | Copyright © May 2023
Shah M, Wald J, Hanke CW. Eruptive Squamous cell carcinomas following treatment with fludarabine and discussion of treatment. J Drugs Dermatol. 2023;22(5):509-510....
Read MoreDilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series
May 2023 | Volume 22 | Issue 5 | Case Reports | 507 | Copyright © May 2023
Media and other results for: "chemotherapy"